Defining and Communicating Value

BIO President and CEO Jim Greenwood has defined value-based agreements as an important part of “the future of drug pricing.” In an op-ed published by The Hill, Greenwood wrote:“Doctors and hospitals are increasingly being paid not for the quantity of care they provide, but for the outcome or quality of care patients receive. The emerging trend in health care is about rewarding value, rather than volume. This is the future, where there is less focus on the number of tests or tre